Healthcare

Request for TOC Request for Sample
BUY NOW

Global Endoscopic Hemostasis Devices (General Surgery) Market – Industry Trends and Forecast to 2029

Healthcare | Upcoming Report | Feb 2022 | Global | 350 Pages | No of Tables: 220 | No of Figures: 60

Report Description

Global Endoscopic Hemostasis Devices (General Surgery) Market, By Mechanical Devices (Clips, Ligation Devices, Suturing Devices and Stents) Injection Devices (Injection and Needles), Thermal Devices (Hemostatic Probes, Hemostatic Forceps, Heater Probe, Argon Plasma Coagulation, Radiofrequency Ablation and Cryotherapy), Topical Devices (Hemostatic Spray and Others), End User Industry (Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights Global Endoscopic Hemostasis Devices (General Surgery) Market

Data Bridge Market Research analyses that the endoscopic hemostasis devices (general surgery) market to growing at a CAGR of 8.90% in the forecast period of 2022-2029.

Endoscopic hemostasis is a medical procedure used to treat gastrointestinal (GI) bleeding. Because the hemostasis treatment is done with an endoscope, it is referred to as endoscopic hemostasis. Mechanical devices, injection devices, thermal devices, and topical devices are among the other types of devices used in the procedure.

The rising prevalence of gastrointestinal (GI) bleeding is the primary factor driving the endoscopic hemostasis market's expansion. Furthermore, rising awareness among healthcare professionals about the benefits of endoscopic hemostasis, as well as rising demand for endoscopic hemostasis techniques, contribute to the market's overall growth. Recent technological advancements in hemostatic clip designs, which aid in the achievement of more effective and long-lasting mechanical hemostasis, are expected to generate profitable opportunities for the market.

The primary driving force behind technological advancements in the gastrointestinal endoscopy device market is a natural preference for less invasive and, ideally, non-invasive treatment methods. This market is steadily expanding its therapeutic reach, addressing conditions that were previously only treatable through more invasive methods and are now treated "through-the-scope."

However, the high cost of endoscopic hemostasis is expected to restrain the market growth. The inability to use another mode of transportation poses a challenge to the market's growth. Also, dearth of skilled medical professionals and required infrastructural facilities in the under developing economies will further derail the market growth.

This endoscopic hemostasis devices (general surgery) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on endoscopic hemostasis devices (general surgery) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Endoscopic Hemostasis Devices (General Surgery) Market Scope and Market Size

The endoscopic hemostasis devices (general surgery) market is segmented on the basis of mechanical devices, injection devices, thermal devices, topical devices and end user industry. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of mechanical devices, the endoscopic hemostasis devices (general surgery) market is segmented into clips, ligation devices, suturing devices and stents.
  • On the basis of injection devices, the endoscopic hemostasis devices (general surgery) market is segmented into injection and needles.
  • On the basis of thermal devices, the endoscopic hemostasis devices (general surgery) market is segmented into hemostatic probes, hemostatic forceps, heater probe, argon plasma coagulation, radiofrequency ablation, and cryotherapy.
  • On the basis of topical devices, the endoscopic hemostasis devices (general surgery) market is segmented into hemostatic spray and others.
  • On the basis of end user industry, the endoscopic hemostasis devices (general surgery) market is segmented into hospitals, specialty clinics, ambulatory surgical centers and others.

Endoscopic Hemostasis Devices (General Surgery) Market Country Level Analysis

The endoscopic hemostasis devices (general surgery) market is analysed and market size insights and trends are provided by country, mechanical devices, injection devices, thermal devices, topical devices and end user industry as referenced above.

The countries covered in the endoscopic hemostasis devices (general surgery) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to the high level of sophistication of healthcare facilities in the region. Asia-Pacific, on the other hand, is expected to grow at a rapid and profitable rate from 2022 to 2029, owing to increased healthcare infrastructure spending, a growing geriatric population, and rising personal disposable income.

The country section of the endoscopic hemostasis devices (general surgery) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The endoscopic hemostasis devices (general surgery) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for endoscopic hemostasis devices (general surgery) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the endoscopic hemostasis devices (general surgery) market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Endoscopic Hemostasis Devices (General Surgery) Market Share Analysis

The endoscopic hemostasis devices (general surgery) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to endoscopic hemostasis devices (general surgery) market.

Some of the major players operating in the endoscopic hemostasis devices (general surgery) market are Boston Scientific Corporation, CONMED Corporation, Cook, Diversatek, Inc., Olympus Corporation, STERIS, Micro-Tech Endoscopy, Integra LifeSciences, Sklar Surgical Instruments, Merit Medical Systems, Abbott, Siemens, ELI Tech Group, HORIBA, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nova Biomedical, Sysmex Corporation and BD among others.


SKU-

Table of Content

Please fill in the below form for detailed Table of Content

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19